Global stock

NYSEUSD

Manulife Financial

MFC

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

68/ 100

Overall score·MFC

Current price

44.65USD

26/10/2026

P/E, P/B

Valuation

Strong

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

P/E 16,7 a PEG 0,93 působí vzhledem k růstu zisku poměrně přiměřeně, zatímco P/B kolem 2,1 u životní pojišťovny není zjevně nízké. Silnějšími stránkami jsou růst zisku, marže a příznivý cenový trend nad oběma klouzavými průměry; slabší je citlivost pojišťovny na trhy, úrokové sazby a pojistné předpoklady.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 57%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Financial results

Financial results·MFC

mld. USD

RevenueEBITDANet incomeEBITDA margin

Margins and profitability·MFC

Net marginEBITDA marginDashed = estimate

Net margin

+8.6 %

FY 2025 · reported

EBITDA margin

+17.4 %

FY 2026 · estimate

Net margin

+20.3 %

last 12 months

Operating margin

+28.2 %

last 12 months

ROE

+13.3 %

last 12 months

FY = fiscal year · TTM = trailing 12 months

§ Context and events

Management

Vedení uvedené v dodaných údajích zahrnuje Colina L. Simpsona, finančního ředitele, Paula Raymona Lorentze v čele Global Wealth & Asset Management, Stevena Andrewa Finche jako CEO Manulife Asia a Brookse Erica Tinglea v čele John Hancock. Strategie zahrnuje pojišťovnictví a správu majetku napříč Asií, Kanadou a USA.

Articles about Manulife Financial, in Czech (0)

No articles yet. New analyses are published daily.

§ Upcoming results

4 November 2026

in 8 days

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is Manulife Financial (MFC)?

Manulife Financial (MFC) is a global stock traded on NYSE. Sector: Insurance and financial services. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Manulife Financial price today?

As of 26 October 2026, Manulife Financial trades at about 44.65 USD per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Manulife Financial?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Manulife Financial pay a dividend?

Manulife Financial either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is Manulife Financial a good investment in 2026?

Our AI signal currently rates Manulife Financial as neutral (score 52/100). Financial health comes out at 68/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More global stocks

Microsoft Corporation

§ How to buy Manulife Financial

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Neutral

Earnings in 8 days

On 4 November 2026 the company publishes its quarterly results. This period tends to bring large price moves — the signal below does not reflect the results yet.

News summary

Older news

Signal 24/10, 17:01

Manulife Investments oznámila hotovostní distribuce za říjen 2026 pro své ETF a ETF série fondů; dopad na MFC závisí na rozsahu a reakci investorů.

Cena je za 7 dní téměř beze změny a za měsíc mírně výš; neutrální trend a momentum 45 neposkytují jasný směr. Pojišťovací a investiční činnost Manulife přináší diverzifikaci, ale citlivost na trhy zůstává.

Risks: Výraznější pohyb trhů nebo změny sazeb mohou zhoršit investiční výnosy a změnit současný neutrální výhled.

More about the signal

Risks: Výraznější pohyb trhů nebo změny sazeb mohou zhoršit investiční výnosy a změnit současný neutrální výhled.

Signal history· 2

22/1023:0262 · Slightly positive
Manulife Bank představila nový přístup k odměnám zaměřený na zdraví, majetek a dlouhověkost; další reakce klientů by ukázala, zda má iniciativa obchodní význam.
12/1012:3149 · Neutral
Manulife Investments 5. října 2026 oznámila uvedení tří nových ETF a jedné nové ETF třídy; rozšíření nabídky může podpořit správu aktiv, pokud získá významný zájem investorů, samotné oznámení však nedokládá obchodní dopad na MFC.

The full 90-day signal history is part of Premium.

Ask the AI

DCF valuation

A DCF model is not suitable for this asset class.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 15 of 18

Valuation score

1/ 6

2/6 tests available

1. Below DCF fair value

The complete DCF range or the current price is missing.

2. Well below DCF value

The complete DCF range or the current price is missing.

3. Price vs. the last year

92% above the 1-year low (33.40 USD to 45.62 USD), based on stored daily prices.

4. P/E vs. similar companies

The sector sample has only 7 companies; scoring needs at least 8.

5. P/E relative to growth

PEG 0.9; a lower value means cheaper growth.

6. Analyst price target

A price target exists, but coverage is too low to count in the score.

Price and fair value

no complete range

The DCF check appears once both the price and the model range are available.

Price vs analyst target

Current price

44.65 USD

Low 34.78 USDHigh 34.78 USD

Current priceAverage: 34.78 USD

DCF gap

no complete range

The DCF check appears once both the price and the model range are available.

Analyst target

-22.1%

Average target 34.78 USD vs. price 44.65 USD.

Analyst consensus

Target range

34.78 USD - 34.78 USD

Coverage

1 analyst

Analyst consensus

2.1 / 5

Changes 180 d

+0 / -0

EPS next year

11.5%

Revenue next year

3.8%

Valuation multiples

16.7

2.1

0.9

52-week range92% above the low

33.40 USD45.62 USD

22.0%

11.0%

20.3%

13.3%

Price vs 50D2.7%

Price vs 200D12.1%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 26/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

strong

Vedení řídí rozsáhlé podnikání napříč pojišťovnictvím a správou majetku v několika regionech a dodaná data ukazují nízké celkové governance riziko.

strong

Konkurenční výhodu podporují dlouhodobá značka, rozsah, distribuční síť a diverzifikovaná klientská základna v pojišťovnictví i správě majetku.

Information

Type: Global stock
Symbol: MFC
Exchange: NYSE
Currency: USD
Sector: Insurance and financial services
: 16.7x
: 73.9B USD
: 42.5 %
: 0.74

§ Risk profile

Výsledky a ocenění mohou kolísat s úrokovými sazbami, výnosy investičního portfolia a tržními cenami aktiv. Českému investorovi přidává měnové riziko kurz CAD či USD vůči koruně.

Ask the AI about Manulife Financial All signals